What is the appropriate dose of regular insulin (Novolin) for an intravenous (IV) push in a patient with severe hyperglycemia (glucose level of 968 mg/dL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Management of Severe Hyperglycemia (Glucose 968 mg/dL)

For a patient with severe hyperglycemia (glucose 968 mg/dL), do NOT give an IV push bolus of regular insulin—instead, initiate a continuous IV insulin infusion at 0.1 units/kg/hour after an initial IV bolus of 0.1 units/kg, following standard hyperglycemic crisis protocols. 1, 2

Critical Initial Assessment

Before administering any insulin, you must immediately check serum potassium levels 1, 2:

  • If potassium <3.3 mEq/L: DO NOT start insulin 2

    • Begin aggressive potassium repletion first (20-40 mEq/L in IV fluids using 2/3 KCl and 1/3 KPO4) 2
    • Obtain ECG to assess cardiac effects 2
    • Delay insulin until K+ ≥3.3 mEq/L to prevent life-threatening arrhythmias and death 2
  • If potassium ≥3.3 mEq/L: Proceed with insulin protocol 1, 2

Fluid Resuscitation (Start Immediately)

Begin isotonic saline at 15-20 mL/kg/hour for the first hour while awaiting potassium results 1, 2. This glucose level (968 mg/dL) meets criteria for hyperosmolar hyperglycemic state (HHS) if pH >7.3 and bicarbonate >15 mEq/L, or diabetic ketoacidosis (DKA) if pH <7.3 and bicarbonate <15 mEq/L 1.

Insulin Protocol (Once K+ ≥3.3 mEq/L)

Continuous IV insulin infusion is the only appropriate therapy for this degree of hyperglycemia—IV push dosing is not a standard protocol 1:

  1. Initial bolus: 0.1 units/kg IV regular insulin 1, 2
  2. Continuous infusion: 0.1 units/kg/hour IV regular insulin 1, 2
  3. Target glucose decline: 50-75 mg/dL per hour 1, 2

Monitoring and Adjustment

  • Check blood glucose every 1 hour initially 1, 2
  • If glucose does not fall by 50 mg/dL in the first hour, verify adequate hydration, then double the insulin infusion rate every hour until achieving steady decline of 50-75 mg/dL/hour 2
  • Check electrolytes, BUN, creatinine, and venous pH every 2-4 hours 1, 2
  • Once glucose reaches 200 mg/dL, add dextrose to IV fluids and reduce insulin infusion to 0.05-0.1 units/kg/hour 2

Common Pitfalls to Avoid

Never give insulin as an IV push for severe hyperglycemia 1, 2. The pharmacologic effect of IV regular insulin begins at 10-15 minutes and terminates at approximately 4 hours 3, making continuous infusion necessary for sustained control. A single IV push would cause unpredictable glucose fluctuations and potential severe hypoglycemia 1.

Do not use subcutaneous insulin for this level of hyperglycemia 1. Continuous insulin infusion remains the therapy of choice for severe hyperglycemia (>300 mg/dL) 1, and subcutaneous insulin should be avoided in critically ill patients, particularly during hypotension or shock 1.

Transition to Subcutaneous Insulin

Only transition when ALL of the following criteria are met 2:

  • Glucose <200 mg/dL
  • pH >7.3 (if DKA)
  • Bicarbonate ≥18 mEq/L (if DKA)
  • Anion gap ≤12 mEq/L (if DKA)
  • Patient can tolerate oral intake

Administer basal insulin (glargine or detemir) subcutaneously 2-4 hours BEFORE stopping IV insulin to prevent rebound hyperglycemia 2. Continue IV insulin for 1-2 hours after giving subcutaneous insulin 2.

Target Glucose Range

For critically ill patients, maintain glucose between 140-180 mg/dL once initial crisis is controlled 1. More stringent targets (110-140 mg/dL) may be appropriate for cardiac surgery patients but increase hypoglycemia risk 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

At what blood glucose level is intravenous (IV) insulin, specifically regular insulin (insulin crystal), indicated for a hospitalized patient with hyperglycemia?
What is the treatment for a patient presenting to the Emergency Room (ER) with hyperglycemia?
What dose of regular insulin is required for a blood glucose level of 452 milligrams per deciliter (mg/dL)?
What is the recommended inpatient management for severe hyperglycemia without Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS), including choice of basal-bolus insulin versus insulin infusion, starting dose for insulin-naïve patients, and monitoring parameters?
What is the cut-off for administering rapid-acting insulin (e.g. aspart, glulisine, or lispro) for treatment of hyperglycemia among elderly frail patients in the Intensive Care Unit (ICU) setting, according to the latest American Diabetes Association (ADA) recommendations?
Why is a patient with a history of low ferritin levels, taking Adderall (amphetamine and dextroamphetamine), and experiencing heavy menstrual bleeding, scheduled for an ablation procedure, feeling her heartbeat, particularly at night, despite having normal blood pressure readings and staying hydrated?
What is the best approach to manage asthma in a pregnant patient?
What is the recommended protocol for a weekly multidisciplinary team meeting to assess progress towards independent breathing in an adult or elderly patient with complex medical conditions requiring prolonged mechanical ventilation?
What are the synergistic effects, potential interactions, and side effects of combining clobazam and levetiracetam in pediatric patients with epilepsy?
How do I advise the family of an adult or elderly patient with a serious or life-altering condition?
Is it safe to use antiseptics in a patient with atrioventricular reentrant tachycardia (AVRT)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.